Pik3ca-amplified Advanced Solid Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-06-28
Clinical Trial Update: A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors [Phase 1, Phase 2]
A Phase Ib/II study evaluating BYL719 (alpelisib) in combination with AMG 479 (motesanib) in adults with PIK3CA-mutated or PIK3CA-amplified …